openPR Logo
Press release

AI in Drug Discovery Market to Soar, Reaching Nearly USD 1.95 Bn by 2030

04-11-2025 12:39 PM CET | Health & Medicine

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

AI in Drug Discovery Market to Soar, Reaching Nearly USD 1.95 Bn

✦ AI in Drug Discovery Market Set to Surge with 29.6% CAGR, Reaching $1.95 Billion by 2030

The global Artificial Intelligence (AI) in Drug Discovery market is experiencing significant growth, with projections indicating a compound annual growth rate (CAGR) of 29.6% from 2024 to 2030. The market, valued at USD 0.15 billion in 2023, is expected to reach nearly USD 1.95 billion by 2030.

Curious to peek inside? Grab your sample copy of this report now:https://www.maximizemarketresearch.com/request-sample/161733/

✦ Market Dynamics and Competitive Landscape

The integration of AI in drug discovery processes is revolutionizing the pharmaceutical industry by enhancing efficiency and reducing the time and cost associated with traditional methods. Key players driving this transformation include NVIDIA Corporation, Exscientia, Google, BenevolentAI, Recursion, Insilico Medicine, Schrödinger, Inc., Microsoft, Atomwise Inc., Illumina, Inc., Valo Health, Merck KGaA, IQVIA, CytoReason, and AbCellera.

Eager to discover what's within? Secure your sample copy of the report today:https://www.maximizemarketresearch.com/request-sample/161733/

✦ Regional Demand and Growth

North America currently dominates the AI in drug discovery market, attributed to high healthcare expenditure, substantial investments in healthcare technologies, and a focus on personalized medicine. However, the Asia-Pacific region is anticipated to exhibit the highest growth rate during the forecast period, driven by increasing adoption of AI technologies and rising healthcare investments.

✦ Country-Specific Insights

Growth Opportunities in Vietnam

Vietnam is emerging as a potential market for AI in drug discovery, with increasing government initiatives to modernize healthcare infrastructure and promote technological advancements in the pharmaceutical sector.

Opportunity Trends in Thailand

Thailand's focus on becoming a medical hub in Asia is fostering opportunities for AI integration in drug discovery, supported by investments in research and development and collaborations with international biotech firms.

Trends in Japan

Japan is witnessing significant advancements in AI-driven drug discovery, with companies like Nxera partnering with AI firms to enhance drug development processes.

Consolidation in South Korea

South Korea is experiencing consolidation in the AI drug discovery market, with mergers and partnerships aimed at strengthening research capabilities and accelerating drug development timelines.

Updation in Singapore

Singapore continues to update its healthcare strategies by integrating AI technologies in drug discovery, supported by government funding and a robust ecosystem for biotech startups.

Growth in the United States

The United States remains a leader in AI-driven drug discovery, with significant investments from companies like AMD, which invested $20 million in Absci Corp. to enhance biologics innovation.

Opportunity Trends in China

China is capitalizing on AI technologies to streamline drug discovery processes, with increased funding and policy support aimed at fostering innovation in the pharmaceutical industry.

Consolidation in Europe

Europe is seeing consolidation in the AI drug discovery sector, with companies like Merck KGaA focusing on partnerships with AI firms such as Biolojic Design, Caris Life Sciences, BenevolentAI, and Exscientia to expedite drug development.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:https://www.maximizemarketresearch.com/request-sample/161733/

✦ Recent Developments

AMD's $20 million investment in Absci Corp. marks its entry into AI-backed drug discovery, aiming to accelerate biologics innovation.

Merck KGaA's strategic partnerships with AI firms highlight a shift towards collaborative approaches in drug development.

✦ AI in Drug Discovery Market Classifications

by Offering

Software
Services
Hardware

by Therapeutic

Area Oncology
Neurology
Cardiovascular Diseases
Metabolic Diseases
Immunology
Others

by Technology

Machine Learning
Natural Language Processing
Others

by Application

Target Selection and Validation
Drug Screening and Lead Optimization
Clinical Studies
Preclinical studies
Others

For deeper market insights, peruse the summary of the research report:

✦ The following companies are included in the market for AI in Drug Discovery :

1. GNS Healthcare (US)
2. BioSymetrics (US)
3. BPGbio, Inc (US)
4. Atomwise Inc (US)
5. Insitro (US)
6. NVIDIA Corporation (US)
7. IBM Corporation (US)
8. Microsoft Corporation (US)
9. Aria Pharmaceuticals, Inc. (US)
10. Insilico Medicine (US)
11. NuMedii, Inc. (US)
12. Owkin Inc. (US)
13. Schrödinger, Inc. (US)
14. DEEP GENOMICS (Canada)
15. Cyclica (Canada)
16. BenevolentAI (UK)
17. Exscientia (UK)
18. Iktos (France)
19. Euretos (Netherlands)
20. Evaxion Biotech A/S (Denmark)

✦ Get Market Research Latest Trends:

global N95 Mask Market https://www.maximizemarketresearch.com/market-report/global-n95-mask-market/105931/

Global Hypothermia Cap Market https://www.maximizemarketresearch.com/market-report/global-hypothermia-cap-market/107669/

Global Podiatry Equipment Market https://www.maximizemarketresearch.com/market-report/global-podiatry-equipment-market/73791/

Global Metachromatic Leukodystrophy Treatment Market https://www.maximizemarketresearch.com/market-report/global-metachromatic-leukodystrophy-treatment-market-industry-analysis-and-forecast-2020-2026-by-type-treatment-type-sales-channel-and-region/111959/

Global Rheumatoid Arthritis Diagnosis Market https://www.maximizemarketresearch.com/market-report/global-rheumatoid-arthritis-diagnosis-market/112472/
Global Bone Marrow Aspirate Concentrates (BMAC) Market https://www.maximizemarketresearch.com/market-report/global-bone-marrow-aspirate-concentrates-bmac-market/37078/

Global Dialysis Disposable Devices Market https://www.maximizemarketresearch.com/market-report/global-dialysis-disposable-devices-market/106788/

Global Uro-Gynaecological Surgical Devices Market https://www.maximizemarketresearch.com/market-report/global-uro-gynaecological-surgical-devices-market/82678/

Oral Solid Dosage Pharmaceutical Formulation Market https://www.maximizemarketresearch.com/market-report/oral-solid-dosage-pharmaceutical-formulation-market/121388/

Oil Change Service Market https://www.maximizemarketresearch.com/market-report/oil-change-service-market/201385/

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI in Drug Discovery Market to Soar, Reaching Nearly USD 1.95 Bn by 2030 here

News-ID: 3967221 • Views:

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Global Magnetic Synthesizers Market to Rise from USD 19.02 Billion in 2024 to USD 33.17 Billion by 2032 at 7.2% CAGR - Magnetic Synthesizers Forecast
Global Magnetic Synthesizers Market to Rise from USD 19.02 Billion in 2024 to US …
Opening Paragraph According to a new report by Maximize Market Research, the global Magnetic Synthesizers Market was valued at USD 19.02 billion in 2024 and is projected to reach USD 33.17 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2032. Key growth drivers include increasing needs for voltage regulation, demand for power quality solutions in high-capacity industrial applications, and expansion of critical infrastructure
Small Molecule Targeted Cancer Therapy Market to Rise from USD 87.76 Billion in 2024 to USD 133.66 Billion by 2032 at 5.4% CAGR - Small Molecule Targeted Cancer Therapy Forecast
Small Molecule Targeted Cancer Therapy Market to Rise from USD 87.76 Billion in …
Opening Paragraph According to a new report by Maximize Market Research, the global Small Molecule Targeted Cancer Therapy Market was valued at USD 87.76 billion in 2024 and is projected to reach USD 133.66 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.4% over the forecast period. The growth is being driven by increasing prevalence of cancer types treatable by small-molecule therapeutics, expanded adoption of precision medicine,
Global Automotive Active Body Panel Market to Grow from USD 1.78 Billion in 2024 to USD 2.90 Billion by 2032 at 6.3% CAGR - Active Body Panel Market Forecast
Global Automotive Active Body Panel Market to Grow from USD 1.78 Billion in 2024 …
Opening Paragraph According to a new report by Maximize Market Research, the global Automotive Active Body Panel Market was valued at USD 1.78 billion in 2024 and is projected to reach USD 2.90 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.3% over the forecast period 2025-2032. Key drivers include the rise of electric and hybrid vehicles, stricter emission norms, and demand for advanced aerodynamic features in
Global Traffic Sign Recognition System Market to Grow from USD 42.11 Billion in 2024 to USD 55.45 Billion by 2032 at a 3.5% CAGR - Traffic Sign Recognition System Forecast
Global Traffic Sign Recognition System Market to Grow from USD 42.11 Billion in …
◉Opening Paragraph According to a new report by Maximize Market Research, the global Traffic Sign Recognition System (TSRS) Market was valued at USD 42.11 billion in 2024 and is projected to reach USD 55.45 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.5% over the forecast period. This growth is being fueled by increasing integration of ADAS (Advanced Driver Assistance Systems), strict safety regulations-especially in Europe-and rising

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase